Skip to main content

diabetes research Archives

New phenotyping program to bolster global diabetes research efforts

Nov. 9, 2017—The use of human pancreatic islets to conduct diabetes-related research has greatly expanded in recent years, and a Human Islet Phenotyping Program (HIPP) at Vanderbilt University Medical Center has been established to provide important islet data to investigators worldwide.

Read more


Pancreatic islets study may spur diabetes treatment advances

Sep. 21, 2017—Investigators in the Vanderbilt Diabetes Research and Training Center (VDRTC) and collaborators at Stanford University have discovered new insights into the molecular mechanisms of cell proliferation in juvenile human pancreatic islets, information that could lead to new treatments for diabetes.

Read more


Vanderbilt mourns loss of diabetes research icon ‘Rollo’ Park

May. 12, 2016—Charles Rawlinson “Rollo” Park, M.D., a pioneering diabetes researcher at Vanderbilt University Medical Center, died Saturday, May 7, at his home in Brentwood, just two months after celebrating his 100th birthday on March 2.

Read more


University-wide limited submission opportunity: American Diabetes Association

Mar. 30, 2016—Vanderbilt may nominate one Medical Center and one university candidate for the 2015 Pathway to Stop Diabetes awards competition.

Read more


Vanderbilt study finds erectile dysfunction drug may benefit patients at risk for diabetes

Nov. 18, 2015—The drug sildenafil, sold as Viagra and other brand names, improves insulin sensitivity in people at risk for diabetes, researchers at Vanderbilt University Medical Center reported. Sildenafil inhibits an enzyme called phosphodiesterase 5 (PDE5), resulting in relaxation of smooth muscle, vasodilation and increased blood flow. Sildenafil is used to treat erectile dysfunction and pulmonary arterial...

Read more


Study tracks insulin’s risks as second-line diabetes medication

Jun. 12, 2014—In an observational study by researchers at Vanderbilt University Medical Center, adults with type 2 diabetes who take insulin in addition to the recommended first-line drug therapy, metformin, had a 30 percent higher risk of heart attack, stroke or death when compared to similar patients who instead augment their metformin regimen with a sulfonylurea.

Read more


ADA, Vanderbilt united in fight against diabetes

Nov. 29, 2012—The statistics are jarring. More than 25.8 million children and adults in the United States — 8.3 percent of the population — have diabetes. And predictions are that one in three people will have the chronic disease by 2050.

Read more


Awards honor diabetes research contributions

Nov. 29, 2012—The recent “Diabetes Day” symposium recognized two Vanderbilt trainees for their potential as future leaders in diabetes research and one longtime staff member for his service to the diabetes research community.

Read more


Study seeks new ways to help teens manage type 1 diabetes

Nov. 8, 2012—Shelagh Mulvaney, Ph.D., assistant professor of Nursing, leads a national team of researchers, engineers and designers that recently landed a $1.8 million federal grant to identify new ways to teach critical problem-solving skills to teenagers with type 1 diabetes using an Internet and mobile phone-based system.

Read more


Alerts ease surgery for patients with diabetes

Nov. 8, 2012—A monitoring and alert system developed and implemented at Vanderbilt University Medical Center that prompts caregivers to check glucose levels for patients with diabetes while they are undergoing surgery has been found to help improve outcomes such as reduced abnormal glucose values, fewer surgical site infections and reduced hospital readmissions after surgery.

Read more


Upcoming Events

MORE EVENTS »